Angelika Mühlebner Selected Research

Angelika Mühlebner Research Topics

Disease

26	Tuberous Sclerosis (Bourneville's Disease) 05/2024 - 01/2016
17	Epilepsy (Aura) 02/2024 - 01/2016
12	Seizures (Absence Seizure) 06/2022 - 11/2016
12	Focal Cortical Dysplasia 01/2022 - 02/2012
6	Inborn Genetic Diseases (Disease, Hereditary) 02/2024 - 11/2016
6	Drug Resistant Epilepsy 01/2022 - 02/2012
5	Astrocytoma (Pilocytic Astrocytoma) 11/2022 - 11/2017
3	Intellectual Disability (Idiocy) 02/2024 - 01/2017
3	Neuroinflammatory Diseases 10/2022 - 01/2019
3	Inflammation (Inflammations) 10/2021 - 01/2016
3	Malformations of Cortical Development 10/2021 - 11/2017
2	Neoplasms (Cancer) 02/2024 - 01/2022
2	Autistic Disorder (Autism) 02/2024 - 01/2017
2	Brain Neoplasms (Brain Tumor) 11/2022 - 11/2017
2	Ganglioglioma 10/2022 - 06/2018
2	Autism Spectrum Disorder 01/2022 - 10/2020
2	Temporal Lobe Epilepsy 10/2021 - 01/2020
2	Status Epilepticus (Complex Partial Status Epilepticus) 10/2021 - 01/2018
2	Carcinogenesis 01/2020 - 06/2018
2	Hamartoma 01/2020 - 01/2016
2	Infantile Spasms (West Syndrome) 10/2019 - 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2024
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022
1	Vaccinia 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Neurodevelopmental Disorders 10/2021
1	Hippocampal Sclerosis 10/2021
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2021
1	Cognitive Dysfunction 10/2020
1	Neurocutaneous Syndromes (Phakomatoses) 01/2020
1	Hydrocephalus (Hydrocephaly) 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Hemimegalencephaly 01/2019
1	Glioma (Gliomas) 06/2018
1	Glioblastoma (Glioblastoma Multiforme) 06/2018
1	Ketosis 01/2018
1	Vomiting 01/2018
1	Nervous System Diseases (Neurological Disorders) 11/2016
1	Gliosis 01/2016
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2015

Drug/Important Bio-Agent (IBA)

26	trans-sodium crocetinate (crocetin)IBA 05/2024 - 01/2016
6	TOR Serine-Threonine KinasesIBA 01/2022 - 01/2016
4	Mechanistic Target of Rapamycin Complex 1IBA 10/2021 - 01/2016
4	mitomycin C-dextranIBA 10/2021 - 01/2019
3	Sirolimus (Rapamycin)FDA Link 11/2022 - 01/2017
3	Anticonvulsants (Antiepileptic Drugs)IBA 11/2017 - 01/2015
2	CytokinesIBA 10/2022 - 06/2022
2	Complement System Proteins (Complement)IBA 01/2022 - 09/2019
2	AntioxidantsIBA 10/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2017
2	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2019 - 01/2019
1	CalciumIBA 02/2024
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	Vigabatrin FDA Link 11/2023
1	Interleukin-10 (Interleukin 10)IBA 10/2022
1	ChloridesIBA 06/2022
1	MTOR InhibitorsIBA 01/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Everolimus FDA Link 01/2022
1	polycaprolactoneIBA 10/2021
1	IronIBA 10/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 06/2018
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 01/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017
1	AMPA Receptors (AMPA Receptor)IBA 11/2016

Therapy/Procedure

3	Therapeutics 10/2021 - 02/2012
3	Ketogenic Diet 10/2019 - 01/2015
1	Parenteral Nutrition 01/2018
1	Enteral Nutrition (Feeding, Tube) 01/2018